Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors

Peng Cui1, Jose L Tomsig, William F McCalmont

  • 1Department of Chemistry, University of Virginia, McCormick Road, Charlottesville, VA 22904, USA. pc3n@virginia.edu

Insights

Researchers developed novel phosphonate derivatives that inhibit autotaxin (ATX), an enzyme crucial for cancer cell invasion and spread. These compounds show promise as potential therapeutics for slowing cancer progression.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Autotaxin (ATX) is a key enzyme involved in cancer progression, promoting cell invasion, migration, and angiogenesis.
  • ATX catalyzes the production of lysophosphatidic acid (LPA), a lipid mediator implicated in various cancers.
  • The enzymatic activity of ATX makes it a significant target for developing novel anti-cancer therapies.

Purpose of the Study:

  • To design and synthesize novel phosphonate derivatives based on lysophosphatidic acid (LPA).
  • To evaluate the potential of these derivatives as inhibitors of autotaxin (ATX) activity.
  • To explore the therapeutic utility of ATX inhibitors in combating cancer spread.

Main Methods:

  • Synthesis of a series of beta-keto and beta-hydroxy phosphonate derivatives.
  • Characterization of the synthesized compounds.
  • Assay of inhibitory activity against autotaxin (ATX).

Main Results:

  • Several beta-keto and beta-hydroxy phosphonate derivatives of LPA were successfully synthesized.
  • Some of the synthesized compounds demonstrated potent inhibition of autotaxin (ATX) activity.
  • These findings highlight the potential of these novel compounds as ATX inhibitors.

Conclusions:

  • Novel phosphonate derivatives of LPA have been developed as potential autotaxin (ATX) inhibitors.
  • The synthesized compounds show promise for therapeutic intervention in cancers where ATX plays a critical role.
  • Further research into these compounds could lead to new strategies for inhibiting cancer cell invasion and metastasis.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: